V2 Financial group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

V2 Financial group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$327K	Hold	3,300	–	–	0.12%	91
2026 Q1	$286K	Hold	3,300	–	–	0.13%	86
2025 Q4	$280K	Hold	3,300	–	–	0.14%	80
2025 Q3	$239K	Hold	3,300	–	–	0.13%	78
2025 Q2	$216K	Hold	3,300	–	–	0.13%	78
2025 Q1	$233K	Hold	3,300	–	–	0.15%	74
2024 Q4	$217K	Hold	3,300	–	–	0.13%	78
2024 Q3	$233K	Hold	3,300	–	–	0.15%	69
2024 Q2	$227K	Hold	3,300	–	–	0.15%	69
2024 Q1	$224K	Hold	3,300	–	–	0.15%	64
2023 Q4	$204K	Buy	+3,300	New	+$194K	0.14%	63
2023 Q1	–	Sell	-3,300	Closed	-$205K	–	61
2022 Q4	$205K	Buy	+3,300	New	+$198K	0.16%	60
2022 Q3	–	Sell	-3,300	Closed	-$211K	–	59
2022 Q2	$211K	Hold	3,300	–	–	0.17%	56
2022 Q1	$214K	Hold	3,300	–	–	0.16%	58
2021 Q4	$220K	Hold	3,300	–	–	0.17%	65
2021 Q3	$201K	Hold	3,300	–	–	0.17%	60
2021 Q2	$204K	Buy	+3,300	New	+$201K	0.17%	58

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

V2 Financial group's IHE Position: Q2 2026 in Review

V2 Financial group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 3,300 shares worth $327K. The position accounts for 0.12% of the portfolio, ranked #91.

V2 Financial group first reported a position in IHE in Q2 2021 and has held it in 17 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

V2 Financial group held 3,300 shares of iShares US Pharmaceuticals ETF worth $327K as of Q2 2026.
V2 Financial group left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.12% of V2 Financial group's portfolio in Q2 2026, its #91 holding.
V2 Financial group first reported a position in iShares US Pharmaceuticals ETF in Q2 2021 and has held it in 17 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on V2 Financial group's 13F filing for Q2 2026, filed 11 Aug 2026.